Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors
Jamison, J. K., Zhou, M., Gelmann, E. P., Luk, L., Bates, S. E., Califano, A., & Fojo, T. (2024). Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The Oncologist. https://doi.org/10.1093/oncolo/oyae118
Columbia Affiliation:
Subjects:
Epidemiology and Management of Neuroendocrine Tumors
(OpenAlex Topic)
Small Cell Lung Cancer
(OpenAlex Topic)
Diagnosis and Management of Gestational Trophoblastic Disease
(OpenAlex Topic)
Grants:
U54CA274506
(NIH – National Cancer Institute)
U54CA209997
(NIH – National Cancer Institute)
U01CA272610
(NIH – National Cancer Institute)
U01CA217858
(NIH – National Cancer Institute)
S10OD032433
(NIH – Office of the Director, National Institutes of Health)
S10OD012351
(NIH – Office of the Director, National Institutes of Health)
S10OD021764
(NIH – Office of the Director, National Institutes of Health)
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyae118
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex